Decision Role Preferences for Return of Results from Genome Sequencing amongst Young Breast Cancer Patients

Genome sequencing is on the rise in both the clinical and research settings [1,2], since rapidly improving technology has decreased the costs and time needed. This has been an important step towards personalized medicine. This test provides vast amounts of information, but there are scientific limitations to interpreting gene variants for clinical use. As such, it is uncertain how to best use the data and how to communicate results to patients, even in the research setting [3 –5]. There are many types of information that can result from the use of sequencing technologies including information about: risk of preventable disease, risk of non-preventable disease, risk of future disease for relatives, and efficacy of medications to name a few [1,5–7].
Source: Patient Education and Counseling - Category: International Medicine & Public Health Authors: Source Type: research